4/3/24 18:50 | 4/2/24 | XLO | Health | BioPrd | Biological Products, (No Diag | Gilead Sciences, Inc. | CA | T | | P.d | 369 | 0.7600 | 0 | 485 | 7 | 7,345 | D | | | | | | | | | | | | | | |
2/9/24 16:33 | 2/8/24 | XLO | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Xi, L.P. | MA | T | | S | -1 | 0.6400 | 0 | -1 | 0 | 2,754 | M | | | | | | | | | | | | | | |
1/16/24 18:16 | 1/11/24 | XLO | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Xi, L.P. | MA | T | | S.m | -4 | 0.8502 | 0 | -4 | 0 | 2,755 | M | | | | | | | | | | | | | | |
12/10/21 20:33 | 12/8/21 | XLO | Health | Drug | Pharmaceutical Preparations | Bain Capital Life Sciences Investors, LLC | MA | T | | P.m | 410 | 9.66 | 0 | 42 | 2 | 2,805 | I | | | | | | | | | | | | | | |
11/3/21 16:20 | 10/26/21 | XLO | Health | Drug | Pharmaceutical Preparations | Sv7 Impact Medicine Fund LP | X0 | T | | P.ad | 10,000 | 16.00 | 0 | 625 | 24 | 3,227 | M | | | | | | | | | | | | | | |
10/28/21 19:15 | 10/26/21 | XLO | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | P.d | 12,400 | 16.00 | 0 | 775 | 51 | 2,288 | I | | | | | | | | | | | | | | |
10/26/21 17:30 | 10/26/21 | XLO | Health | Drug | Pharmaceutical Preparations | Rivervest Venture Fund Iv, L.P. | MO | T | | P.d | 4,000 | 16.00 | 0 | 250 | 21 | 1,441 | I | | | | | | | | | | | | | | |
10/26/21 17:04 | 10/26/21 | XLO | Health | Drug | Pharmaceutical Preparations | Rock Springs Capital Management LP | MD | T | | P.d | 8,000 | 16.00 | 0 | 500 | 66 | 1,256 | I | | | | | | | | | | | | | | |
10/26/21 17:02 | 10/26/21 | XLO | Health | Drug | Pharmaceutical Preparations | Bay City Capital LLC | CA | T | | P.d | 5,000 | 16.00 | 0 | 313 | 38 | 1,129 | I | | | | | | | | | | | | | | |
10/26/21 17:01 | 10/26/21 | XLO | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Xi, L.P. | MA | T | | P.d | 3,000 | 16.00 | 0 | 188 | 34 | 736 | I | | | | | | | | | | | | | | |